The Science of Possibility

At Hubble Therapeutics, we’re driven by a shared vision: restoring sight and transforming lives. Meet the passionate team behind our groundbreaking work in gene therapy for LCA16. Together, we’re shaping a brighter future, one breakthrough at a time.

• Single Treatment
• Safe and well-tolerated vector
• Clear clinical endpoints
• Established regulatory path

Our Approach to Innovation

Hubble Therapeutics combines advanced gene therapy techniques with rigorous research to address the genetic root causes of LCA16. By leveraging cutting-edge protein technology, we aim to develop targeted, effective treatments that restore vision and redefine possibilities for patients.

Transforming Genetics into Solutions

Our science focuses on precision and impact. By delivering therapeutic genes directly to affected cells, we tackle inherited blindness at its source. This pioneering approach has the potential to create lasting change, giving hope to those impacted by rare genetic conditions.